Tim Mullaney writes mostly on economics, health care and technology. He was national economics correspondent at USA Today from 2011 to 2014 and earlier served as E-Business Editor of BusinessWeek. Follow him on Twitter at @timmullaney.
Americans are unwittingly contributing to the opioid epidemic by leaving a massive supply of unused painkillers in circulation.
Statins are cheaper than ever, but new drugs, called PCSK9 inhibitors, are putting heart disease at center of battle over drug prices.
Elon Musk is Tesla's key asset. He needs a succession and business continuity plan to ensure the company stays on a growth trajectory.
There are good reasons for a healthy business to lose money early on. Jeff Bezos, Elon Musk and Mark Zuckerberg show how it's done.
Amazon's master plan for Whole Foods is still a mystery. Earnings day is the first chance for analysts to ask the online giant about it.
Defying skeptics, Tesla's stock is up 50% this year. Here's what experts say Elon Musk should do now to keep his car company on track.
As fired FBI director Comey testifies in the Senate, it's a long shot, but it is time to think about market reaction to a 'President' Pence.
Larry Fink started BlackRock in a single room with 8 executives in 1988. It’s now the world’s largest asset manager. Here's how Fink thinks.
Big stock market names are betting European and emerging market stocks offer better value than US equities. But what about bonds?
No one has done a better job of succeeding in the world of media than Walt Disney CEO Bob Iger. Here are his 6 power commandments.